Stress-Delta Biomarkers for Acute Coronary Syndrome Risk Stratification
Abbott Stress-Delta Biomarkers for ACS Risk Stratification
1 other identifier
observational
125
1 country
1
Brief Summary
Acute Coronary Syndrome (ACS) is a serious heart condition that is a leading cause of death in America. Cardiac stress testing is currently the best test to non-invasively identify which patients might be having ACS and may need more invasive testing such as a cardiac catheterization (placing a tube in the heart) for coronary angiogram (invasive mapping of the blood vessels of the heart). However, stress tests require imaging by highly trained specialists and even then may not correctly categorize a small minority of patients being evaluated for ACS. Advances in blood tests may now allow detection of the very early stages of heart blood vessel blockage via a simple blood test. The investigators seek to determine whether these blood tests can help to better identify patients with ACS. The study will also store any extra blood sample that may be left over for future use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 18, 2016
CompletedFirst Posted
Study publicly available on registry
March 24, 2016
CompletedStudy Start
First participant enrolled
August 10, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 7, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 11, 2019
CompletedAugust 19, 2019
August 1, 2019
1.7 years
March 18, 2016
August 16, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
% Post Stress-Delta
1-hour Post-Stress Troponin I - Resting Baseline Troponin I)/ Resting Baseline Troponin I
1 hour
% 2-hour Stress-Delta
(3-hour Post-Stress Troponin I - Resting Baseline Troponin I)/ Resting Baseline Troponin I
2 hour
Secondary Outcomes (2)
Delta BNP values
1hr
Delta BNP values
2hr
Study Arms (1)
ACS Patients
Subjects will be patients presenting to the Emergency Department for evaluation of ACS.
Eligibility Criteria
Potential participants are patients presenting to the Emergency Department for evaluation of ACS.
You may qualify if:
- Any patient presenting to the ED with clinical suspicion of ACS as determined by the treating emergency physician. These include symptoms including but not limited to chest pain, pressure, or burning sensation across the precordium.
- Age 40 years or older.
You may not qualify if:
- Patient with cardiac marker diagnosis of acute myocardial infarction or who otherwise is not a candidate for a cardiac stress test.
- Evidence of serious arrhythmias or acute MI or ischemia on ECG
- Unstable vital signs: persistent (\> 2 readings or over 2 hours) hypotension (systolic blood pressure \< 80 mm Hg), pulse \> 110 beats per minute.
- Any medical condition that would be worsened by cardiac stress
- Aortic aneurysm or dissection
- Active myocarditis or pericarditis
- Ventricular dysrhythmia or significant atrial dysrhythmia
- Severe or greater degree of aortic stenosis
- Acute or decompensated heart failure or pulmonary edema
- Pulmonary embolism
- Aortic aneurysm
- Patient is non-English speaking.
- Patient is incarcerated or a prisoner.
- Patient does not have capacity to consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexander T Limkakeng, MD
Duke University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 18, 2016
First Posted
March 24, 2016
Study Start
August 10, 2016
Primary Completion
May 7, 2018
Study Completion
June 11, 2019
Last Updated
August 19, 2019
Record last verified: 2019-08